Skip to main content
Screener/Healthcare/Biotechnology

TVTX — Travere Therapeutics, Inc.

NASDAQ
$56.15-1.21 (-2.11%)
Mid CapHealthcareFastest Growing
$15.03
$60.10
$55.30
$57.55
EPS (TTM)$-0.53
P/E Ratio-73.46
Dividend Yield—
Market Cap$5.17B
Volume986K
Prev Close$57.28
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$127.2M-$37.1M$-0.4079.0%-29.2%
Q4 '25$129.7M-$22.0M$-0.2484.0%-17.0%
Q3 '25$164.9M$25.7M$0.2599.0%15.6%
Q2 '25$114.4M-$12.8M$-0.1498.7%-11.1%
Q1 '25$81.7M-$41.2M$-0.4794.3%-50.4%
Q4 '24$74.8M-$60.3M$-0.7396.6%-80.6%
Q3 '24$62.9M-$54.8M$-0.7097.4%-87.1%
Q2 '24$54.1M-$70.4M$-0.9177.1%-130.1%
Get Your Daily Market Recap